Press & News

Real-world data highlights how Viz.ai accelerates access to ICH treatment SAN FRANCISCO – June 9, 2025 - Viz.ai, the leader...

Multi-year collaboration with Novartis to develop AI-powered workflows for prostate and breast cancer, helping to reach patients eligible to benefit...

Comprehensive suite of solutions designed to empower oncology care teams, accelerating patient diagnosis and treatment Viz.ai’s strategic expansion into new...

Companies will collaborate on an AI-powered care improvement solution for patients with high-risk COPD SAN FRANCISCO – May 20, 2025...

New feature provides AI-enhanced 3D imaging to improve neurovascular visualization and streamline workflows SAN FRANCISCO – April 30, 2025 -...

Real-world evidence supports Viz ICH Plus for reliable volume and midline shift estimation SAN FRANCISCO – April 23, 2025 –...

Honored for excellence and innovation in cardiovascular health diagnostics for Viz HCM module SAN FRANCISCO – April 4, 2025 –...

Real-world evidence to be presented at the American College of Cardiology Scientific Session 2025 demonstrates positive impact of Viz.ai on...

SAN FRANCISCO – March 18, 2025 - Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced...